Sarah Leigh Nicholson

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

David W. Ellison, James Dalton, Mehmet Koçak et al. · Acta Neuropathologica · 2011 · 557 citations

Veterinary Medicine, Cancer Biology, Oncology +13

Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables

David W. Ellison, Mehmet Koçak, James Dalton et al. · Journal of Clinical Oncology · 2010 · 300 citations

Medicine, Oncology, Pathology +17

Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease

Rebecca M. Hill, Sanne Kuijper, Janet C. Lindsey et al. · Cancer Cell · 2014 · 213 citations · Full text

Medicine, Genetics, Oncology +17

MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma

Sarra Ryan, Ed C. Schwalbe, Michael Cole et al. · Acta Neuropathologica · 2011 · 109 citations · Full text

Medicine, Genetics, Oncology +15

mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis

Shireena A. Yasin, Abu M. Ali, Mathew Tata et al. · Acta Neuropathologica · 2013 · 82 citations

Life Sciences, Developmental Biology, Neuroscience +17